Cadara™, formerly National Care Systems, today announced a strategic partnership with Waystar and the availability of Cadara Exchange™, an integrated experience purpose-built for post-acute revenue management. The solution connects Cadara RLM™, Cadara's cloud-based billing and revenue management software, directly with Waystar's AI-powered revenue cycle platform, helping post-acute organizations eliminate workflow fragmentation that drains productivity, limits visibility, and delays revenue.
Detailed price information for Sandisk Corp (SNDK-Q) from The Globe and Mail including charting and trades.
Detailed price information for Waystar Holding Corp (WAY-Q) from The Globe and Mail including charting and trades.
Waystar Holding Corp (WAY) posts 21% revenue growth and raises full-year adjusted EBITDA guidance, though Q4 revenue growth is guided to slow to about 6% on Iodine timing and print-to-digital shifts.
Investing.com -- Waystar Holding Corp (NASDAQ:WAY) reported third quarter results that exceeded analyst expectations, but shares fell 7.3% in after-hours trading Monday as the company's full-year guidance disappointed investors.
Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today reported results for the third quarter ended September 30, 2026.
Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, and Modern Healthcare today announced new research showing that payer recoupments create significant financial exposure, drain staff capacity, and make it harder for healthcare organizations to protect revenue after payment.
Detailed price information for FMC Corp (FMC-N) from The Globe and Mail including charting and trades.
Detailed price information for Idexx Laboratories (IDXX-Q) from The Globe and Mail including charting and trades.
Waystar (WAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Detailed price information for Os Therapies Incorporated (OSTX-A) from The Globe and Mail including charting and trades.
Waystar stock catapulted Tuesday on reports the medical software company is exploring strategic options.
Waystar (NASDAQ:WAY) shares rose 3. 3% to $25.
Waystar (WAY) is seeking options including a potential sale, Reuters reported Tuesday, citing seven
All three major US stock indexes were down in late-morning trading Tuesday, as Treasury yields conti
Detailed price information for Waystar Holding Corp (WAY-Q) from The Globe and Mail including charting and trades.
Waystar (WAY) management reaffirmed guidance for low-double-digit revenue growth and a 40% adjusted
Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today unveiled new Waystar AltitudeAI-powered agentic capabilities that autonomously take action across critical revenue cycle workflows, advancing the company's vision for an autonomous revenue cycle.
This is the newest page. Registered accounts read further back.